Microfluidics-Based Biomarker Isolation and Detection
Isolate and detect rare biomarkers in blood samples, such as CTCs, cfDNA, and exosomes.
This technology allows large-volume, whole-blood processing with high biomarker recovery and purity. The technology is based on microfluidic isolation technology and has been clinically validated for six different cancer types. Source
Get started
To start making requests, simply fill out the registration form below.
Have an account? Sign in.